Injective Protocol (INJ) traded at $7.26 on November 1, 2026, gaining 2.59% over the prior 24-hour period. The move offered a modest reprieve for holders of the asset after a stretch of negative performance across longer measurement windows.
Over the past seven days, INJ declined 3.68%, while the 30-day change came in at a nearly identical loss of 3.70%. The convergence of those two figures suggests the bulk of the recent drawdown occurred earlier in the monthly period, with price action stabilizing more recently.
The token's market capitalization stood at $0.74 billion at the time of measurement, placing it among the mid-tier assets in the broader cryptocurrency market. Trading volume and order-book depth were not provided in the available data.
The one-day gain has not been sufficient to recover the losses accumulated over the weekly and monthly windows, leaving INJ in negative territory on both timeframes despite the latest uptick.
